2017年1月~6月PubMed検索結果


このページには,2017年1月から6月に,PubMedで検索したPSPに関する英語論文の「掲載雑誌名と巻号など,論文タイトル,著者,PubMedID」を載せていきます。


【2017/1/7 検索】
1. Parkinsonism Relat Disord. 2016 Dec 26. pii: S1353-8020(16)30516-8. doi: 10.1016/j.parkreldis.2016.12.023. [Epub ahead of print]
Advanced structural neuroimaging in progressive supranuclear palsy: Where do we stand?
Stezin A1, Lenka A1, Jhunjhunwala K1, Saini J2, Pal PK3.
PMID: 28057431 [PubMed – as supplied by publisher]


【2017/1/14 検索】
1. Neurol Sci. 2017 Jan 11. doi: 10.1007/s10072-017-2812-1. [Epub ahead of print]
MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson’s disease.
Kim BC1,2, Choi SM3,4,5, Choi KH6, Nam TS6, Kim JT1, Lee SH1, Park MS1, Yoon W7.
PMID: 28078564 [PubMed – as supplied by publisher]


2. Acta Neuropathol. 2017 Jan 7. doi: 10.1007/s00401-016-1665-7. [Epub ahead of print]
Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series.
Yoshida K1, Hata Y2, Kinoshita K2, Takashima S1, Tanaka K1, Nishida N3.
PMID: 28064358 [PubMed – as supplied by publisher]


3. BMJ Open. 2017 Jan 7;7(1):e013187. doi: 10.1136/bmjopen-2016-013187.
Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses.
Bevan-Jones WR1, Surendranathan A1, Passamonti L2, Vázquez Rodríguez P2, Arnold R1, Mak E1, Su L1, Coles JP3, Fryer TD4, Hong YT4, Williams G4, Aigbirhio F4, Rowe JB2, O’Brien JT1.
Free PMC Article
PMID: 28064175 [PubMed – in process]


4. Parkinsonism Relat Disord. 2017 Jan 3. pii: S1353-8020(16)30522-3. doi: 10.1016/j.parkreldis.2016.12.029. [Epub ahead of print]
Abnormal dopamine transporter imaging in adult-onset Niemann-Pick disease type C.
Terbeek J1, Latour P2, Van Laere K3, Vandenberghe W 4.
PMID: 28063684 [PubMed – as supplied by publisher]


【2017/1/21 検索】
1. Neurology. 2017 Jan 18. pii: 10.1212/WNL.0000000000003615. doi: 10.1212/WNL.0000000000003615. [Epub ahead of print]
Genome-wide association study identifies MAPT locus influencing human plasma tau levels.
Chen J1, Yu JT1, Wojta K1, Wang HF1, Zetterberg H1, Blennow K1, Yokoyama JS1, Weiner MW1, Kramer JH1, Rosen H1, Miller BL1, Coppola G1, Boxer AL2; Alzheimer’s Disease Neuroimaging Initiative.
Collaborators: (65)
PMID: 28100725 [PubMed – as supplied by publisher]


2. Neurology. 2017 Jan 17;88(3):e32-e33. doi: 10.1212/WNL.0000000000003520.
Teaching Video NeuroImages: Alternating horizontal single saccadic pulses in progressive supranuclear palsy.
Lee ES1, Choi JY1, Kim JS2.
PMID: 28093520 [PubMed – in process]


3. Brain. 2017 Jan 12. pii: aww339. doi: 10.1093/brain/aww339. [Epub ahead of print]
Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.
Ono M1,2, Sahara N1, Kumata K1, Ji B1, Ni R3, Koga S4, Dickson DW4, Trojanowski JQ5, Lee VM5, Yoshida M6, Hozumi I7, Yoshiyama Y8, van Swieten JC9, Nordberg A3, Suhara T1, Zhang MR1, Higuchi M10.
PMID: 28087578 [PubMed – as supplied by publisher]


【2017/1/28 検索】
1. Brain Behav. 2016 Oct 31;7(1):e00598. doi: 10.1002/brb3.598. eCollection 2017.
Serum uric acid levels in Parkinson’s disease and related disorders.
Sakuta H1, Suzuki K1, Miyamoto T2, Miyamoto M3, Numao A1, Fujita H1, Watanabe Y1, Hirata K1.
PMID: 28127516 [PubMed – in process]


2. Brain. 2017 Jan 24. pii: aww340. doi: 10.1093/brain/aww340. [Epub ahead of print]
18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy.
Passamonti L1,2, Vázquez Rodríguez P3, Hong YT3,4, Allinson KS5, Williamson D4, Borchert RJ3, Sami S3, Cope TE3, Bevan-Jones WR6, Jones PS3, Arnold R6, Surendranathan A6, Mak E6, Su L6, Fryer TD3,4, Aigbirhio FI3,4, O’Brien JT6, Rowe JB3,3.
PMID: 28122879 [PubMed – as supplied by publisher]
★★★PSPA-Funded Research,英国の患者家族団体が資金を拠出した研究★★★


3. IEEE/ACM Trans Comput Biol Bioinform. 2016 May 9. doi: 10.1109/TCBB.2016.2564970. [Epub ahead of print]
Brain Modulyzer: Interactive Visual Analysis of Functional Brain Connectivity.
Murugesan S, Bouchard K, Brown JA, Hamann B, Seeley WW, Trujillo A, Weber GH.
PMID: 28113724 [PubMed – as supplied by publisher]


【2017/2/4 検索】
1. Mov Disord. 2017 Feb 2. doi: 10.1002/mds.26921. [Epub ahead of print]
Manual MRI morphometry in Parkinsonian syndromes.
Möller L1, Kassubek J2, Südmeyer M3,4, Hilker R5, Hattingen E6, Egger K7, Amtage F8, Pinkhardt EH2, Respondek G1,9,10, Stamelou M1, 11, Möller F12, Schnitzler A3, Oertel WH1, Knake S1, Huppertz HJ13, Höglinger GU 1,8,9.
PMID: 28150443 [PubMed – as supplied by publisher]


2. EMBO Mol Med. 2017 Feb 1. pii: e201606664. doi: 10.15252/emmm.201606664. [Epub ahead of print]
PERK activation mitigates tau pathology in vitro and in vivo.
Bruch J1,2,3, Xu H1,2,3, Rösler TW1,2, De Andrade A 1,3, Kuhn PH4,5, Lichtenthaler SF3,4,6, Arzberger T7, Winklhofer KF3,8, Müller U9, Höglinger GU10,2,3.
© 2017 The Authors. Published under the terms of the CC BY 4.0 license.
Free Article
PMID: 28148553 [PubMed – as supplied by publisher]


3. J Neurol Sci. 2017 Feb 15;373:216-222. doi: 10.1016/j.jns.2017.01.003. Epub 2017 Jan 4.
Potential multisystem degeneration in Asidan patients.
Ohta Y1, Yamashita T1, Hishikawa N1, Sato K1, Matsuzono K1, Tsunoda K1, Hatanaka N1, Takemoto M1, Takemi T2, Takamatsu K3, Abe K4.
PMID: 28131191 [PubMed – in process]


4. J Neurol Sci. 2017 Feb 15;373:157-166. doi: 10.1016/j.jns.2016.12.049. Epub 2016 Dec 27.
Cortical control of vertical and horizontal saccades in progressive supranuclear palsy: An exploratory fMRI study.
Lemos J1, Pereira D2, Almendra L3, Rebelo D4, Patrício M5, Castelhano J4, Cunha G2, Januário C6, Cunha L6, Freire A6, Castelo-Branco M7.
PMID: 28131178 [PubMed – in process]


【2017/2/11 検索】
1. Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003680. doi: 10.1212/WNL.0000000000003680. [Epub ahead of print]
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Hansson O1, Janelidze S2, Hall S2, Magdalinou N2, Lees AJ2, Andreasson U2, Norgren N2, Linder J2, Forsgren L2, Constantinescu R2, Zetterberg H2, Blennow K2; Swedish BioFINDER study.
Collaborators: (25)
Minthon L, Toresson H, Nägga K, Palmqvist S, Stomrud E, Johansson P, Nilsson C, Nilsson M, Mattsson N, Lindqvist D, Vestberg S, Janelidze S, van Westen D, Lätt J, Mannfolk P, Nilsson M, Strandberg O, Sundgren P, Ståhlberg F, Lindberg O, Westman E, Wahlund LO, Wollmer P, Smith R, Olsson T.
PMID: 28179466 [PubMed – as supplied by publisher]


2. PLoS One. 2017 Feb 3;12(2):e0170927. doi: 10.1371/journal.pone.0170927. eCollection 2017.
Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments.
Clerici I1, Ferrazzoli D1, Maestri R2, Bossio F1, Zivi I1, Canesi M3, Pezzoli G3, Frazzitta G1.
TRIAL REGISTRATION:
This trial was registered on ClinicalTrials.gov, NCT02109393.
Free Article
PMID: 28158197 [PubMed – in process]


3. J Cereb Blood Flow Metab. 2016 Jan 1:271678X16683695. doi: 10.1177/0271678X16683695. [Epub ahead of print]
Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.
Coakeley S1,2, Cho SS1,2, Koshimori Y1,2, Rusjan P1, Harris M1, Ghadery C1,2, Kim J1,2, Lang AE3, Wilson A1, Houle S1, Strafella AP1,2,3.
PMID: 28155586 [PubMed – as supplied by publisher]


【2017/2/18 検索】
1. Neuropsychologia. 2017 Feb 13. pii: S0028-3932(17)30056-8. doi: 10.1016/j.neuropsychologia.2017.02.010. [Epub ahead of print]
Deconstructing empathy: Neuroanatomical dissociations between affect sharing and prosocial motivation using a patient lesion model.
Shdo SM1, Ranasinghe KG1, Gola KA1, Mielke CJ1, Sukhanov PV1, Miller BL1, Rankin KP2.
PMID: 28209520 [PubMed – as supplied by publisher]


2. PLoS One. 2017 Feb 16;12(2):e0172145. doi: 10.1371/journal.pone.0172145. eCollection 2017.
Side effects induced by the acute levodopa challenge in Parkinson’s Disease and atypical parkinsonisms.
Vasta R1, Nicoletti A1, Mostile G1, Dibilio V1, Sciacca G1, Contrafatto D1, Cicero CE1, Raciti L1, Luca A1, Zappia M1.
Free Article
PMID: 28207803 [PubMed – in process]


3. Curr Opin Toxicol. 2016 Dec;1:71-79. doi: 10.1016/j.cotox.2016.09.001. Epub 2016 Sep 28.
Gene regulatory effects of disease-associated variation in the NRF2 network.
Lacher SE1, Slattery M2.
PMID: 28203648 [PubMed]


4. Alzheimers Dement. 2017 Feb 11. pii: S1552-5260(17)30010-9. doi: 10.1016/j.jalz.2017.01.006. [Epub ahead of print]
Cerebrospinal fluid markers detect Alzheimer’s disease in nonamnestic dementia.
Oboudiyat C1, Gefen T2, Varelas E2, Weintraub S2, Rogalski E2, Bigio EH2, Mesulam MM2.
PMID: 28196768 [PubMed – as supplied by publisher]


5. Toxicol Appl Pharmacol. 2017 Feb 10. pii: S0041-008X(17)30066-2. doi: 10.1016/j.taap.2017.02.009. [Epub ahead of print]
Thiamine deficiency induces endoplasmic reticulum stress and oxidative stress in human neurons derived from induced pluripotent stem cells.
Wang X1, Xu M1, Frank JA1, Ke ZJ2, Luo J3.
PMID: 28193519 [PubMed – as supplied by publisher]


【2017/2/25 検索】
1. Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30014-6. doi: 10.1016/j.jalz.2016.12.014. [Epub ahead of print]
Free and Cued Selective Reminding Test-accuracy for Alzheimer’s and neurodegenerative disease differential diagnosis: A large-scale biomarker-characterized monocenter cohort study (ClinAD).
Teichmann M1, Epelbaum S2, Samri D3, Levy Nogueira M4, Michon A3, Hampel H5, Lamari F6, Dubois B7.
PMID: 28222300 [PubMed – as supplied by publisher]


2. Neurobiol Sleep Circadian Rhythms. 2017 Jan;2:4-14. doi: 10.1016/j.nbscr.2016.08.002. Epub 2016 Aug 10.
Sleep in Alzheimer’s Disease – Beyond Amyloid.
Holth J1, Patel T1, Holtzman DM1.
PMCID: PMC5312809 [Available on 2018-01-01]
PMID: 28217760 [PubMed]


3. J Neurol Neurosurg Psychiatry. 2017 Feb 18. pii: jnnp-2016-315192. doi: 10.1136/jnnp-2016-315192. [Epub ahead of print]
Peduncolopontine nucleus stimulation in progressive supranuclear palsy: a randomised trial.
Scelzo E1,2,3, Lozano AM4, Hamani C4, Poon YY5, Aldakheel A1, Zadikoff C6, Lang AE5, Moro E7,5.
PMID: 28214797 [PubMed – as supplied by publisher]


4. Parkinsonism Relat Disord. 2017 Jan 31. pii: S1353-8020(17)30030-5. doi: 10.1016/j.parkreldis.2017.01.016. [Epub ahead of print]
Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics.
Magdalinou NK1, Noyce AJ2, Pinto R3, Lindstrom E4, Holmén-Larsson J4, Holtta M4, Blennow K4, Morris HR5, Skillbäck T4, Warner TT2, Lees AJ2, Pike I6, Ward M6, Zetterberg H7, Gobom J4.
PMID: 28214264 [PubMed – as supplied by publisher]


【2017/3/4 検索】
1. Parkinsonism Relat Disord. 2017 Feb 24. pii: S1353-8020(17)30077-9. doi: 10.1016/j.parkreldis.2017.02.027. [Epub ahead of print]
Pathologic correlates of supranuclear gaze palsy with parkinsonism.
Martin WR1, Hartlein J2, Racette BA3, Cairns N4, Perlmutter JS5.
PMID: 28256434 [PubMed – as supplied by publisher]


2. J Neurol Neurosurg Psychiatry. 2017 Mar 1. pii: jnnp-2016-314956. doi: 10.1136/jnnp-2016-314956. [Epub ahead of print]
Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis.
Glasmacher SA1, Leigh PN2, Saha RA3.
PMID: 28250027 [PubMed – as supplied by publisher]


3. Proc Natl Acad Sci U S A. 2017 Feb 28. pii: 201616892. doi: 10.1073/pnas.1616892114. [Epub ahead of print]
Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease.
Dunn AR1, Stout KA1, Ozawa M1, Lohr KM1, Hoffman CA1, Bernstein AI1, Li Y1,2, Wang M1, Sgobio C3, Sastry N3, Cai H3, Caudle WM1, Miller GW4,2,5,6.
Free Article
PMID: 28246328 [PubMed – as supplied by publisher]


4. Eur J Neurol. 2017 Feb 28. doi: 10.1111/ene.13269. [Epub ahead of print]
Evaluation of an optimized [18 F]fluoro-deoxy-glucose positron emission tomography voxel-wise method to early support differential diagnosis in atypical Parkinsonian disorders.
Caminiti SP1,2, Alongi P3, Majno L1, Volontè MA4, Cerami C2,5, Gianolli L3, Comi G4, Perani D1,2,3.
PMID: 28244178 [PubMed – as supplied by publisher]


5. J Neural Transm (Vienna). 2017 Feb 27. doi: 10.1007/s00702-017-1700-4. [Epub ahead of print]
Differentiation of atypical Parkinson syndromes.
Höglinger GU1,2, Kassubek J3, Csoti I4, Ehret R5, Herbst H6, Wellach I7, Winkler J8, Jost WH9.
PMID: 28243754 [PubMed – as supplied by publisher]


6. Brain Behav. 2016 Dec 5;7(2):e00616. doi: 10.1002/brb3.616. eCollection 2017.
Weight loss in the early stage of progressive supranuclear palsy.
Tsuge A1, Kaneko S1, Wate R1, Oki M1, Nagashima M1, Asayama S1, Nakamura M1, Fujita K1, Saito A1, Takenouchi N2, Kusaka H1.
PMCID: PMC5318369 Free PMC Article
PMID: 28239526 [PubMed – in process]


7. Parkinsonism Relat Disord. 2016 Dec 14. pii: S1353-8020(16)30489-8. doi: 10.1016/j.parkreldis.2016.12.006. [Epub ahead of print]
“Atypical” atypical parkinsonism: Critical appraisal of a cohort.
Hirschbichler ST1, Erro R2, Ganos C3, Stamelou M4, Batla A1, Balint B5, Bhatia KP6.
PMID: 28236526 [PubMed – as supplied by publisher]


【2017/3/11 検索】
1. Curr Med Res Opin. 2017 Mar 2:1-14. doi: 10.1080/03007995.2017.1294054. [Epub ahead of print]
The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease.
Hendriksz CJ1,2, Anheim M3, Bauer P4,5, Bonnot O6 , Chakrapani A7, Corvol JC8, de Koning TJ9, Degtyareva A10, Dionisi-Vici C11, Doss S12, Duning T13, Giunti P14, Iodice R15, Johnston T16, Kelly D17, Klünemann HH18, Lorenzl S19,20, Padovani A21, Pocovi M22, Synofzik M23,24, Terblanche A2, Then Bergh F 25, Topçu M26, Tranchant C27, Walterfang M28, Velten C29, Kolb SA29.
PMID: 28276873

2. Acta Neuropathol. 2017 Mar 7. doi: 10.1007/s00401-017-1693-y. [Epub ahead of print]
Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.
Yokoyama JS1, Karch CM2, Fan CC3, Bonham LW4, Kouri N5, Ross OA5, Rademakers R5, Kim J5, Wang Y6, Höglinger GU7, Müller U8, Ferrari R9, Hardy J9; International FTD-Genomics Consortium (IFGC), Momeni P10, Sugrue LP11, Hess CP11, James Barkovich A11, Boxer AL4, Seeley WW4, Rabinovici GD4, Rosen HJ4, Miller BL4, Schmansky NJ12, Fischl B12,13, Hyman BT14, Dickson DW5, Schellenberg GD15, Andreassen OA7, Dale AM3,16, Desikan RS17.
PMID: 28271184

3. Neurodegener Dis. 2017 Mar 8;17(4-5):117-126. doi: 10.1159/000454880. [Epub ahead of print]
Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
Vintonyak O1, Gorges M, Müller HP, Pinkhardt EH, Ludolph AC, Huppertz HJ, Kassubek J.
PMID: 28268209

4. Neurobiol Aging. 2017 Feb 10. pii: S0197-4580(17)30037-4. doi: 10.1016/j.neurobiolaging.2017.02.002. [Epub ahead of print]
Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.
Gatto EM1, Allegri RF2, Da Prat G3, Chrem Mendez P4, Hanna DS5, Dorschner MO5, Surace EI6, Zabetian CP7, Mata IF8.
PMID: 28268100

5. PLoS One. 2017 Mar 7;12(3):e0173351. doi: 10.1371/journal.pone.0173351. eCollection 2017.
Impaired perception of surface tilt in progressive supranuclear palsy.
Dale ML1,2, Horak FB1,2, Wright WG3, Schoneburg BM1, Nutt JG1, Mancini M1.
Free Article
PMID: 28267762

6. An Sist Sanit Navar. 2015 Jan-Apr;38(1):79-92.
[Neuropsychological profile of frontotemporal lobar degeneration].
[Article in Spanish]
Carmona-Abellán MM1, Luquin MR, Lamet I, Pujol Giménez N, Esteve-Belloch P, Rivero M.
Free Article
PMID: 25963461 [Indexed for MEDLINE]


【2017/3/18 検索】
1. Acta Neuropathol. 2017 Mar 14. doi: 10.1007/s00401-017-1692-z. [Epub ahead of print]
Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid.
Saijo E1, Ghetti B2, Zanusso G3, Oblak A2, Furman JL4, Diamond MI4, Kraus A1, Caughey B5.
PMID: 28293793

2. Bioinformation. 2016 Nov 30;12(10):391-395. doi: 10.6026/97320630012391. eCollection 2016.
Pharmacophore feature-based virtual screening for finding potent GSK-3 inhibitors using molecular docking and dynamics simulations.
Chauhan N1, Gajjar A2, Basha SH3.
PMCID: PMC5320924 Free PMC Article
PMID: 28293069

3. Parkinsonism Relat Disord. 2017 Mar 6. pii: S1353-8020(17)30082-2. doi: 10.1016/j.parkreldis.2017.03.001. [Epub ahead of print]
White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study.
Zanigni S1, Evangelisti S1, Testa C1, Manners DN1, Calandra-Buonaura G2, Guarino M3, Gabellini A4, Gramegna LL1, Giannini G2, Sambati L2, Cortelli P2, Lodi R5, Tonon C1.
PMID: 28291592

4. Parkinsonism Relat Disord. 2017 Mar 6. pii: S1353-8020(17)30083-4. doi: 10.1016/j.parkreldis.2017.03.002. [Epub ahead of print]
IgLON5 autoimmunity tested negative in patients with progressive supranuclear palsy and corticobasal syndrome.
Mangesius S1, Sprenger F2, Höftberger R3, Seppi K4, Reindl M5, Poewe W6.
PMID: 28285943


【2017/3/25 検索】
1. Brain. 2017 Feb 9. doi: 10.1093/brain/awx005. [Epub ahead of print]
A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction.
Lopez A1,2, Lee SE3,4, Wojta K5,4, Ramos EM5,4 , Klein E5,4, Chen J5,4, Boxer AL3,4, Gorno-Tempini ML3,4, Geschwind DH5,4, Schlotawa L1,2, Ogryzko NV6, Bigio EH7,4, Rogalski E7,4, Weintraub S7,4, Mesulam MM7,4, Fleming A1,2, Coppola G5,4, Miller BL3,4, Rubinsztein DC1.
PMID: 28334843

2. Front Neurosci. 2017 Mar 7;11:100. doi: 10.3389/fnins.2017.00100. eCollection 2017.
Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI Study.
Mueller K1, Jech R2, Bonnet C2, Tintěra J3 , Hanuška J2, Möller HE1, Fassbender K4, Ludolph A5, Kassubek J5, Otto M5, Růžička E2, Schroeter ML6; FTLDc Study Group.
PMCID: PMC5339275 Free Article
PMID: 28326008

3. Neuropsychologia. 2017 Mar 18;99:207-212. doi: 10.1016/j.neuropsychologia.2017.03.021. [Epub ahead of print]
Bilingualism delays the onset of behavioral but not aphasic forms of frontotemporal dementia.
Alladi S1, Bak TH2, Shailaja M3, Gollahalli D4, Rajan A5, Surampudi B6, Hornberger M7, Duggirala V8, Chaudhuri JR9, Kaul S10.
PMID: 28322905

4. Parkinsonism Relat Disord. 2017 Mar 15. pii: S1353-8020(17)30103-7. doi: 10.1016/j.parkreldis.2017.03.008. [Epub ahead of print]
Functional disconnection of thalamic and cerebellar dentate nucleus networks in progressive supranuclear palsy and corticobasal syndrome.
Upadhyay N1, Suppa A2, Piattella MC1, Giannì C1, Bologna M2, Di Stasio F3, Petsas N1, Tona F1, Fabbrini G2, Berardelli A2, Pantano P4.
PMID: 28318985

5. Ageing Res Rev. 2017 Mar 15;36:50-63. doi: 10.1016/j.arr.2017.03.002. [Epub ahead of print]
In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
Hall B1, Mak E1, Cervenka S2, Aigbirhio FI3 , Rowe JB4, O’Brien JT5.
PMID: 28315409

6. Tidsskr Nor Laegeforen. 2016 Dec 20;136(23-24):1998. doi: 10.4045/tidsskr.16.0558. eCollection 2016.
Kolibri på MR-bilde.
[Article in Norwegian]
Lindstad CB1, Herder M2, Albretsen C3.
Free Article
PMID: 28004549 [Indexed for MEDLINE]


【2017/4/1 検索】
1. Transl Neurodegener. 2017 Mar 28;6:8. doi: 10.1186/s40035-017-0076-6. eCollection 2017.
Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts.
Saeed U1, Compagnone J1, Aviv RI2, Strafella AP3, Black SE4, Lang AE5, Masellis M6.
PMCID: PMC5370489
PMID: 28360997

2. Alzheimers Res Ther. 2017 Mar 31;9(1):25. doi: 10.1186/s13195-017-0253-y.
Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.
Ng KP1,2,3, Pascoal TA1, Mathotaarachchi S1, Therriault J1, Kang MS1, Shin M1, Guiot MC4, Guo Q5, Harada R6, Comley RA5, Massarweh G7, Soucy JP7, Okamura N8, Gauthier S3, Rosa-Neto P9,10,11,12.
PMID: 28359327

3. J Phys Ther Sci. 2017 Mar;29(3):558-562. doi: 10.1589/jpts.29.558. Epub 2017 Mar 22.
Disordered voluntary cough as freezing phenomenon in parkinsonism.
Ishii M1, Mashimo H2.
PMCID: PMC5361033
PMID: 28356654
※日本人の先生の論文

4. Parkinsonism Relat Disord. 2017 Jan;34:7-14. doi: 10.1016/j.parkreldis.2016.10.013. Epub 2016 Oct 19.
Palliative care and its emerging role in Multiple System Atrophy and Progressive Supranuclear Palsy.
Wiblin L1, Lee M2, Burn D3.
PMID: 28341224
※療養介護に関する論文

This review aims to discuss the trajectory of disease in MSA and PSP, explore significant symptoms and summarize some evidence which exists for palliative care need and quality of life in these conditions.
The challenges of a palliative approach with this group including advance care planning will also be discussed.


【2017/4/8 検索】
1. Neuroradiology. 2017 Apr 6. doi: 10.1007/s00234-017-1812-4. [Epub ahead of print]
Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.
Sakurai K1, Tokumaru AM2, Shimoji K2, Murayama S 3, Kanemaru K3, Morimoto S3, Aiba I4, Nakagawa M5, Ozawa Y5, Shimohira M5, Matsukawa N6, Hashizume Y7, Shibamoto Y5.
PMID: 28386688
※日本人の先生たちの論文

2. Rev Neurol (Paris). 2017 Apr 3. pii: S0035-3787(16)30139-4. doi: 10.1016/j.neurol.2017.03.007. [Epub ahead of print]
GABA spectra and remote distractor effect in progressive supranuclear palsy: A pilot study.
Bonnet C1, Rusz J2, Hanuška J3, Dezortová M 4, Jírů F4, Sieger T5, Jech R6, Klempíř J6, Roth J6, Bezdíček O6, Serranová T6, Dušek P6, Uher T6, Flammand-Roze C7, Hájek M4, Růžička E8 .
PMID: 28385472

3. Neurology. 2017 Apr 5. pii: 10.1212/WNL.0000000000003887. doi: 10.1212/WNL.0000000000003887. [Epub ahead of print]
Clinical manifestations of the anti-IgLON5 disease.
Gaig C1, Graus F2, Compta Y1, Högl B1, Bataller L1, Brüggemann N1, Giordana C1, Heidbreder A1, Kotschet K1, Lewerenz J1, Macher S1, Martí MJ1, Montojo T1, Pérez-Pérez J1, Puertas I1, Seitz C1, Simabukuro M1, Téllez N1, Wandinger KP1, Iranzo A1, Ercilla G1, Sabater L1, Santamaría J1, Dalmau J1.
PMID: 28381508

※PSPの論文ではない
Among 16 patients with paired serum and CSF samples, 14 had IgLON5 antibodies in both, and 2 only in serum (both had a PSP-like syndrome).
Twenty of 21 patients had IgG1 and IgG4 antibodies; the latter predominated in 16.

4. Neurol Res. 2017 Apr 5:1-10. doi: 10.1080/01616412.2017.1312211. [Epub ahead of print]
The utility of FDG-PET in the differential diagnosis of Parkinsonism.
Brajkovic L1, Kostic V2,3, Sobic-Saranovic D1,3, Stefanova E2, 3, Jecmenica-Lukic M2, Jesic A1, Stojiljkovic M1, Odalovic S1,3, Gallivanone F4, Castiglioni I4, Radovic B1,5, Trajkovic G1,6, Artiko V1,3.
PMID: 28378615

5. J Neural Transm (Vienna). 2017 Apr 4. doi: 10.1007/s00702-017-1717-8. [Epub ahead of print]
Magnetic resonance imaging for the diagnosis of Parkinson’s disease.
Heim B1, Krismer F2, De Marzi R1, Seppi K3,4.
PMID: 28378231
※画像診断に関する総説
This review aims to summarize research findings regarding the value of the different MRI techniques, including advanced sequences at high- and ultra-high-field MRI and modern image analysis algorithms, in the diagnostic work-up of Parkinson’s disease.

6. Neuroimage Clin. 2017 Jan 17;14:672-678. doi: 10.1016/j.nicl.2017.01.016. eCollection 2017.
A neural network underlying intentional emotional facial expression in neurodegenerative disease.
Gola KA1, Shany-Ur T1, Pressman P1, Sulman I1, Galeana E1, Paulsen H1, Nguyen L1, Wu T1, Adhimoolam B1, Poorzand P1, Miller BL1, Rankin KP1.
PMCID: PMC5367861 Free PMC Article
PMID: 28373956

7. Tremor Other Hyperkinet Mov (N Y). 2017 Mar 20;7:449. doi: 10.7916/D80G3QWB. eCollection 2017.
High-voltage VIM Region Deep Brain Stimulation Mimicking Progressive Supranuclear Palsy.
Patterson A1, Okun MS1, Hess C1.
PMCID: PMC5374517 Free PMC Article
PMID: 28373925

8. Neuropathol Appl Neurobiol. 2017 Apr 2. doi: 10.1111/nan.12400. [Epub ahead of print]
Tau aggregates: Where, When, Why and What consequences?
Frosch MP1.
PMID: 28370398
※論説(Editorial)

9. Neuropathol Appl Neurobiol. 2017 Mar 30. doi: 10.1111/nan.12401. [Epub ahead of print]
Tau aggregates: Where, When, Why and What consequences?
Frosch MP1.
PMID: 28370167
※論説(Editorial) 8番と同じ論説のようだが掲載号が異なる?

10. Mov Disord Clin Pract. 2017 Jan-Feb;4(1):42-45. doi: 10.1002/mdc3.12348. Epub 2016 May 19.
Central hypoventilation in progressive supranuclear palsy.
Herrick KS1, Woltjer R1, Pham T1, Chalupsky M1, Hiller AL2.
PMCID: PMC5370587 [Available on 2018-01-01]
PMID: 28367478
※中枢性低換気症候群が発現した症例報告。剖検で,特に腹側呼吸ニューロン群(ventral respiratory group,VRG)にタウオパチーを認めた。

11. AJNR Am J Neuroradiol. 2017 Mar 31. doi: 10.3174/ajnr.A5136. [Epub ahead of print]
Combined Diffusion Tensor Imaging and Apparent Transverse Relaxation Rate Differentiate Parkinson Disease and Atypical Parkinsonism.
Du G1, Lewis MM2, Kanekar S2, Sterling NW2, He L2, Kong L2, Li R2, Huang X1.
PMID: 28364007

12. J Recept Signal Transduct Res. 2016 Aug;36(4):395-401. doi: 10.3109/10799893.2015.1108337. Epub 2015 Nov 25.
Curcumin inhibits apoptosis by regulating intracellular calcium release, reactive oxygen species and mitochondrial depolarization levels in SH-SY5Y neuronal cells.
Uğuz AC1,2, Öz A1, Nazıroğlu M1,2.
PMID: 26608462 [Indexed for MEDLINE]


【2017/4/15 検索】
1. J Parkinsons Dis. 2017 Apr 13. doi: 10.3233/JPD-160945. [Epub ahead of print]
The Role of Stress as a Risk Factor for Progressive Supranuclear Palsy.
Kelley KD1, Peavy G2, Edland S2, Rogers W3, Riley DE4, Bordelon Y5, Standaert D6, Reich SG7, Litvan I2.
PMID: 28409749

2. Oncotarget. 2017 Mar 29. doi: 10.18632/oncotarget.16690. [Epub ahead of print]
Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.
Zhang CC1, Zhu JX2, Wan Y3, Tan L4, Wang HF2, Yu JT3, Tan L1,3,4.
Free Article
PMID: 28402959

3. Mov Disord. 2017 Apr 10. doi: 10.1002/mds.27005. [Epub ahead of print]
Brain PET imaging of phosphodiesterase 10A in progressive supranuclear palsy and Parkinson’s disease.
Koole M1, Laere KV1, Ahmad R1, Ceccarini J1, Bormans G2, Vandenberghe W3.
PMID: 28394032

4. Neurol Sci. 2017 Apr 7. doi: 10.1007/s10072-017-2936-3. [Epub ahead of print]
Combined visual and semi-quantitative assessment of 123I-FP-CIT SPECT for the diagnosis of dopaminergic neurodegenerative diseases.
Ueda J1, Yoshimura H2, Shimizu K3, Hino M3, Kohara N1.
PMID: 28389938
※日本人の先生たちの論文


【2017/4.22 検索】
1. Front Neuroinform. 2017 Mar 30;11:23. doi: 10.3389/fninf.2017.00023. eCollection 2017.
Multivariate Analysis of 18F-DMFP PET Data to Assist the Diagnosis of Parkinsonism.
Segovia F1,2, Górriz JM1, Ramírez J1, Martínez-Murcia FJ 1, Levin J3, Schuberth M3, Brendel M4, Rominger A4, Bötzel K3, Garraux G2, Phillips C2.
PMCID: PMC5371594 Free Article
PMID: 28424607

2. Intern Med. 2017;56(8):907-914. doi: 10.2169/internalmedicine.56.7879. Epub 2017 Apr 15.
Factors Associated with Pneumonia-caused Death in Older Adults with Autopsy-confirmed Dementia.
Manabe T1,2,3,4, Mizukami K4,5, Akatsu H6,7, Hashizume Y6, Ohkubo T2, Kudo K2,8, Hizawa N1.
Free Article
PMID: 28420838
※日本人の先生たちの論文

3. J Mov Disord. 2017 Apr 18. doi: 10.14802/jmd.16059. [Epub ahead of print]
Progressive Supranuclear Gaze Palsy with Predominant Cerebellar Ataxia: A Case Series with Videos.
Xu Z1, Lim TCC2, Au WL1, Tan LCS1.
Free Article
PMID: 28415165
※シンガポール,症例シリーズ

4. Am J Pathol. 2017 Apr 13. pii: S0002-9440(17)30072-X. doi: 10.1016/j.ajpath.2017.01.019. [Epub ahead of print]
Exposure of the Amino Terminus of Tau Is a Pathological Event in Multiple Tauopathies.
Combs B1, Kanaan NM2.
PMID: 28413156

5. Alzheimers Res Ther. 2017 Apr 17;9(1):28. doi: 10.1186/s13195-017-0259-5.
Multireceptor fingerprints in progressive supranuclear palsy.
Chiu WZ1, Donker Kaat L1, Boon AJW1, Kamphorst W2, Schleicher A3, Zilles K3,4,5, van Swieten JC1, Palomero-Gallagher N6,7.
PMCID: PMC5393015 Free PMC Article
PMID: 28412965 [Indexed for MEDLINE]

6. Neurol Clin. 2017 May;35(2):339-374. doi: 10.1016/j.ncl.2017.01.008.
Frontotemporal Dementia.
Olney NT1, Spina S2, Miller BL3.
PMID: 28410663 [Indexed for MEDLINE]


【2017/4/29 検索】
1. Mov Disord. 2017 Apr 24. doi: 10.1002/mds.26973. [Epub ahead of print]
Longitudinal magnetic resonance imaging in progressive supranuclear palsy: A new combined score for clinical trials.
Höglinger GU1,2,3, Schöpe J4, Stamelou M3,5, Kassubek J6, Del Ser T7, Boxer AL8, Wagenpfeil S4, Huppertz HJ9; AL-108-231 Investigators; Tauros MRI Investigators; Movement Disorder Society-Endorsed PSP Study Group.
PMID: 28436538

2. J Med Imaging Radiat Oncol. 2017 Apr 22. doi: 10.1111/1754-9485.12613. [Epub ahead of print]
Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy.
Bacchi S1, Chim I1, Patel S2.
PMID: 28432758


【2017/5/6 検索】
1. Front Aging Neurosci. 2017 Apr 19;9:99. doi: 10.3389/fnagi.2017.00099. eCollection 2017.
Retrospective Diagnosis of Parkinsonian Syndromes Using Whole-Brain Atrophy Rates.
Guevara C1, Bulatova K1, Soruco W1, Gonzalez G1, Farías GA1.
PMCID: PMC5396185
PMID: 28469572

 ↓ 下記は重要文献です
2. Mov Disord. 2017 May 3. doi: 10.1002/mds.26987. [Epub ahead of print]
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
Höglinger GU1,2, Respondek G1,2, Stamelou M3, Kurz C4, Josephs KA5, Lang AE6, Mollenhauer B7, Müller U8, Nilsson C9, Whitwell JL10, Arzberger T2,4,11, Englund E12, Gelpi E13, Giese A11, Irwin DJ14, Meissner WG15, 16,17, Pantelyat A18, Rajput A19, van Swieten JC20, Troakes C21, Antonini A22, Bhatia KP 23, Bordelon Y24, Compta Y25, Corvol JC26, Colosimo C27, Dickson DW28, Dodel R29, Ferguson L19, Grossman M14, Kassubek J30, Krismer F31, Levin J2,32, Lorenzl S33,34, 35, Morris HR36, Nestor P37, Oertel WH38, Poewe W31, Rabinovici G39, Rowe JB40, Schellenberg GD41, Seppi K31, van Eimeren T42, Wenning GK31, Boxer AL39, Golbe LI43, Litvan I44; Movement Disorder Society-endorsed PSP Study Group1.
Collaborators: (45)
PMID: 28467028

※1996年に発表されたNINDS/SPSPによる診断基準では,リチャードソン症候群以外の亜型に対する感度に限界があった。そのため,エビデンスとコンセンサスに基づいた診断基準改定を行なった。

3. J Alzheimers Dis. 2017 Apr 27. doi: 10.3233/JAD-170110. [Epub ahead of print]
Changes of Cerebrospinal Fluid Peptides due to Tauopathy.
Majerova P1,2, Barath P3, Michalicova A1,2, Katina S2,4, Novak M1,2, Kovac A1,2,5.
PMID: 28453489

※ラットモデルを使った基礎試験。

4. Am J Hum Genet. 2016 Sep 1;99(3):735-43. doi: 10.1016/j.ajhg.2016.06.026. Epub 2016 Aug 18.
Absence of the Autophagy Adaptor SQSTM1/p62 Causes Childhood-Onset Neurodegeneration with Ataxia, Dystonia, and Gaze Palsy.
Haack TB1, Ignatius E2, Calvo-Garrido J3, Iuso A 4, Isohanni P2, Maffezzini C5, Lönnqvist T6, Suomalainen A7, Gorza M8, Kremer LS4 , Graf E8, Hartig M9, Berutti R8, Paucar M10, Svenningsson P10, Stranneheim H11, Brandberg G12, Wedell A11, Kurian MA13, Hayflick SA14, Venco P15, Tiranti V15, Strom TM4, Dichgans M16, Horvath R17, Holinski-Feder E18, Freyer C19, Meitinger T20, Prokisch H4, Senderek J21, Wredenberg A19, Carroll CJ7, Klopstock T22.
PMCID: PMC5010644 Free PMC Article
PMID: 27545679 [Indexed for MEDLINE]

※SQSTM1 (sequestosome 1; also known as p62) 遺伝子に関する論文。


【2017/5/13 検索】
1. AJNR Am J Neuroradiol. 2017 May 11. doi: 10.3174/ajnr.A5207. [Epub ahead of print]
Pontomesencephalic Atrophy and Postural Instability in Wilson Disease.
Kalita J1, Naik S2, Bhoi SK2, Misra UK2, Ranjan A2, Kumar S2.
PMID: 28495941

2. Exp Brain Res. 2017 May 10. doi: 10.1007/s00221-017-4978-4. [Epub ahead of print]
Cathepsin S increases tau oligomer formation through limited cleavage, but only IL-6, not cathespin S serum levels correlate with disease severity in the neurodegenerative tauopathy progressive supranuclear palsy.
Nübling G1,2,3, Schuberth M4, Feldmer K5, Giese A6, Holdt LM7, Teupser D7, Lorenzl S4,5,8.
PMID: 28493068

※PSPでも炎症が起きている?
The observed correlation of IL-6 with disease severity warrants further investigation of inflammatory markers in PSP.

3. Parkinsonism Relat Disord. 2017 May 3. pii: S1353-8020(17)30149-9. doi: 10.1016/j.parkreldis.2017.05.002. [Epub ahead of print]
Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
Nigro S1, Morelli M2, Arabia G2, Nisticò R1, Novellino F1, Salsone M1, Rocca F1, Quattrone A3.
PMID: 28487107

4. Brain. 2017 May 9. doi: 10.1093/brain/awx101. [Epub ahead of print]
Apathy and impulsivity in frontotemporal lobar degeneration syndromes.
Lansdall CJ1, Coyle-Gilchrist ITS1, Jones PS1, Vázquez Rodríguez P1, Wilcox A1, Wehmann E1,2, Dick KM3, Robbins TW4,5, Rowe JB1,4,6.
PMID: 28486594

5. J Neurol Sci. 2017 Jun 15;377:174-178. doi: 10.1016/j.jns.2017.04.026. Epub 2017 Apr 17.
Usefulness of combining 123I-FP-CIT-SPECT striatal asymmetry index and cardiac 123I-metaiodobenzylguanidine scintigraphy examinations for diagnosis of parkinsonisms.
Niimi Y1, Ito S1, Murate K1, Hirota S1, Hikichi C1, Ishikawa T1, Maeda T1, Nagao R1, Shima S1, Mizutani Y1, Ueda A1, Mutoh T2.
PMID: 28477690
※日本人の先生たちの論文


【2017/5/20 検索】
1. Parkinsonism Relat Disord. 2017 May 13. pii: S1353-8020(17)30168-2. doi: 10.1016/j.parkreldis.2017.05.006. [Epub ahead of print]
Wall-eyed bilateral internuclear ophtalmoplegia (WEBINO) in a patient with Richardson’s syndrome – Progressive supranuclear palsy.
de Souza LC1, de Paula Franca Resende E2, Magalhaes D3, Teixeira AL4, Gomez RS5.
PMID: 28522172

2. Eur J Neurol. 2017 May 16. doi: 10.1111/ene.13314. [Epub ahead of print]
The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
Silsby M1, Tweedie-Cullen RY2, Murray CR3, Halliday GM3, 4,5, Hodges JR3,4, Burrell JR1,3,4.
PMID: 28510312

3. J Neuropsychiatry Clin Neurosci. 2017 May 16:appineuropsych17010012. doi: 10.1176/appi.neuropsych.17010012. [Epub ahead of print]
Use of the Neuropsychiatric Inventory to Characterize the Course of Neuropsychiatric Symptoms in Progressive Supranuclear Palsy.
Je menica-Luki  M1, Pekmezovi  T1, Petrovi  IN1, Tomi  A1, Svetel M1, Kosti  VS1.
PMID: 28506191

4. Lancet Neurol. 2017 Jun;16(6):478-488. doi: 10.1016/S1474-4422(17)30123-0.
Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate?
Doty RL1.
PMID: 28504111

5. J Neurol Neurosurg Psychiatry. 2017 May 13. pii: jnnp-2017-315607. doi: 10.1136/jnnp-2017-315607. [Epub ahead of print]
Cerebellar atrophy in neurodegeneration-a meta-analysis.
Gellersen HM1, Guo CC2, O’Callaghan C3,4, Tan RH4,5, Sami S6, Hornberger M7,8.
PMID: 28501823

6. Mov Disord. 2017 May 13. doi: 10.1002/mds.27034. [Epub ahead of print]
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Respondek G1,2, Kurz C3, Arzberger T2,3,4, Compta Y5, Englund E6, Ferguson LW7, Gelpi E8, Giese A4, Irwin DJ9, Meissner WG10,11,12, Nilsson C13, Pantelyat A14, Rajput A7, van Swieten JC15, Troakes C16, Josephs KA17, Lang AE18, Mollenhauer B19, Muller U20, Whitwell JL21, Antonini A22, Bhatia KP23, Bordelon Y24, Corvol JC25, Colosimo C26, Dodel R27, Grossman M9, Kassubek J28, Krismer F29, Levin J30, Lorenzl S31,32,33, Morris H34, Nestor P35, Oertel WH36, Rabinovici GD37, Rowe JB38, van Eimeren T39, Wenning GK29, Boxer A37, Golbe LI40, Litvan I41, Stamelou M36,42,43, Hoglinger GU1,2; Movement Disorder Society-Endorsed PSP Study Group.
PMID: 28500752

7. Mov Disord. 2017 May 13. doi: 10.1002/mds.27038. [Epub ahead of print]
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
Whitwell JL1, Hoglinger GU2,3, Antonini A4, Bordelon Y5, Boxer AL6, Colosimo C7, van Eimeren T3,8, Golbe LI9, Kassubek J10, Kurz C11, Litvan I12, Pantelyat A13, Rabinovici G6, Respondek G2,3, Rominger A14, Rowe JB15, Stamelou M16, Josephs KA17; Movement Disorder Society-endorsed PSP Study Group.
PMID: 28500751

8. Biol Psychiatry. 2017 Apr 13. pii: S0006-3223(17)31473-7.
doi: 10.1016/j.biopsych.2017.04.003. [Epub ahead of print]
Prion-like Spreading in Tauopathies.
Ayers JI1, Giasson BI1, Borchelt DR2.
PMID: 28506438

★CBD/CBS論文としてヒットした論文
★異常タウ蛋白の伝播に関する総説
★著者抄録を一部引用します。タウオパチーと一括りにされる病気でも,タウの病理学的特徴は異なっている。たとえばCBDとアルツハイマー病では異なる。
Notably, the pathological features of tau pathology in these diseases can be very distinct.
For example, the tau pathology in corticobasal degeneration is distinct from that of an AD patient.


【2017/5/27 検索】
1. Neuropathology. 2017 May 26. doi: 10.1111/neup.12389. [Epub ahead of print]
Pathology of oligodendroglia: An overview.
Komori T1.
PMID: 28548216
★日本人の先生の論文,東京都立神経病院,小森隆司(こもり たかし)先生

2. Mov Disord. 2017 May 22. doi: 10.1002/mds.27039. [Epub ahead of print]
Intrinsic functional connectivity alterations in progressive supranuclear palsy: Differential effects in frontal cortex, motor, and midbrain networks.
Rosskopf J1, Gorges M1, Müller HP1, Lulé D1, Uttner I1, Ludolph AC1, Pinkhardt E1, Juengling FD2,3, Kassubek J1.
PMID: 28544256

3. Mov Disord. 2017 May 22. doi: 10.1002/mds.27049. [Epub ahead of print]
Muscle ceroid lipofuscin-like deposits in a patient with corticobasal syndrome due to a progranulin mutation.
Terlizzi R1,2, Valentino ML1,2, Bartoletti-Stella A2, Columbaro M3, Piras S1, Stanzani-Maserati M1, Quadri M4, Breedveld GJ4, Bonifati V4, Martinelli P2, Parchi P1,2, Capellari S1,2.
PMID: 28543767
★CBD/CBSの論文としてヒットしたもの。
★17番染色体にあるプログラニュリン(progranulin: PGRN)遺伝子の変異。PGRNは,N結合型の糖蛋白で,エストロゲンにより脳内発現が促進され,脳の性分化や神経新生に関与する分泌型成長因子。中枢神経系ではこの遺伝子変異は認知症を引き起こす。つまり,前頭側頭葉変性症の一部の症例が,PGRN遺伝子変異により発症する。


【2017/6/3 検索】
1. Psychiatry Res. 2017 May 17;265:65-71. doi: 10.1016/j.pscychresns.2017.05.004. [Epub ahead of print]
Morphometric analysis of thalamic volume in progressive supranuclear palsy: In vivo evidence of regionally specific bilateral thalamic atrophy.
Power BD1, Jakabek D2, Hunter-Dickson M3, Wilkes FA4, van Westen D5, Santillo AF6, Walterfang M7, Velakoulis D8, Nilsson C9, Looi JCL10.

PMID: 28550719


【2017/6/10 検索】
1. Oncotarget. 2017 May 23. doi: 10.18632/oncotarget.18193. [Epub ahead of print]
Progressive modulation of the human olfactory bulb transcriptome during Alzheimer’s disease evolution: novel insights into the olfactory signaling across proteinopathies.
Lachen-Montes M1,2, Zelaya MV1,2,3, Segura V2,4, Fernández-Irigoyen J1,2,5, Santamaría E1,2,5.
PMID: 28596505

2. Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004088. doi: 10.1212/WNL.0000000000004088. [Epub ahead of print]
CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.
Alcolea D1, Vilaplana E1, Suárez-Calvet M1, Illán-Gala I1, Blesa R1, Clarimón J1, Lladó A1, Sánchez-Valle R1, Molinuevo JL1, García-Ribas G1, Compta Y1, Martí MJ1, Piñol-Ripoll G1, Amer-Ferrer G1, Noguera A1, García-Martín A1, Fortea J1, Lleó A2.
PMID: 28592456

3. Clin Case Rep. 2017 Apr 26;5(6):1054-1055. doi: 10.1002/ccr3.958. eCollection 2017 Jun.
A 72-year-old with eyelid opening apraxia in Steele-Richardson-Olszewski syndrome.
Qureshi IA1, Qureshi MA1, Maud A1.
PMCID: PMC5458046 Free Article
PMID: 28588873

4. Aging Dis. 2017 May 2;8(3):257-266. doi: 10.14336/AD.2017.0112. eCollection 2017 May.
Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies.
Castillo-Carranza DL1,2, Nilson AN1,2, Van Skike CE3, Jahrling JB3, Patel K1,2, Garach P1,2, Gerson JE1,2, Sengupta U1,2, Abisambra J4, Nelson P5, Troncoso J6, Ungvari Z7, Galvan V3, Kayed R1,2,8.
PMCID: PMC5440106 Free PMC Article
PMID: 28580182

5. Eur J Pharmacol. 2017 Jun 1. pii: S0014-2999(17)30387-4. doi: 10.1016/j.ejphar.2017.05.056. [Epub ahead of print]
Clinical and biological phenotypes of frontotemporal dementia: perspectives for disease modifying therapies.
Gazzina S1, Manes MA1, Padovani A1, Borroni B 2.
PMID: 28579383


【2017/6/17 検索】
1. Neurobiol Dis. 2017 Jun 10. pii: S0969-9961(17)30131-6. doi: 10.1016/j.nbd.2017.06.005. [Epub ahead of print]
Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.
Reilly P1, Winston CN1, Baron K1, Trejo M2, Rockenstein EM1, Akers JC3, Kfoury N4, Diamond M4, Masliah E2, Rissman RA1, Yuan SH5.
PMID: 28610892

2. Neurobiol Aging. 2017 May 17. pii: S0197-4580(17)30164-1. doi: 10.1016/j.neurobiolaging.2017.05.009. [Epub ahead of print]
NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases.
Blauwendraat C1, Faghri F2, Pihlstrom L3, Geiger JT1, Elbaz A4, Lesage S5, Corvol JC5, May P6, Nicolas A7, Abramzon Y7, Murphy NA7, Gibbs JR7, Ryten M8, Ferrari R8, Bras J8, Guerreiro R8, Williams J9, Sims R9, Lubbe S10, Hernandez DG11, Mok KY12, Robak L13, Campbell RH14, Rogaeva E15, Traynor BJ7, Chia R7, Chung SJ16; International Parkinson’s Disease Genomics Consortium (IPDGC); COURAGE-PD Consortium, Hardy JA8, Brice A5, Wood NW17, Houlden H 8, Shulman JM18, Morris HR17, Gasser T19, Krüger R20, Heutink P21, Sharma M22, Simón-Sánchez J21, Nalls MA23, Singleton AB7, Scholz SW24.
PMID: 28602509

3. J Neurol Neurosurg Psychiatry. 2017 Jun 9. pii: jnnp-2017-315857. doi: 10.1136/jnnp-2017-315857. [Epub ahead of print]
Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers.
Jabbari E1, Zetterberg H1,2, Morris HR1.
PMID: 28600442

4. J Neuroinflammation. 2017 Jun 9;14(1):118. doi: 10.1186/s12974-017-0893-7.
YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies.
Querol-Vilaseca M1,2, Colom-Cadena M1,2, Pegueroles J1,2, San Martín-Paniello C1, Clarimon J1,2, Belbin O1,2, Fortea J1,2, Lleó A3,4.
PMCID: PMC5466718 Free PMC Article
PMID: 28599675


【2017/6/24 検索】
1. Front Neurol. 2017 Jun 6;8:248. doi: 10.3389/fneur.2017.00248. eCollection 2017.
Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome.
Bharti K1, Bologna M1,2, Upadhyay N1, Piattella MC1, Suppa A1,2, Petsas N1, Giannì C1, Tona F1, Berardelli A1,2, Pantano P1,2 .
PMCID: PMC5459910 Free Article
PMID: 28634465

2. Neurodegener Dis Manag. 2017 Jun 20. doi: 10.2217/nmt-2017-0005. [Epub ahead of print]
Utility and accuracy of perceptual voice and speech distinctions in the diagnosis of Parkinson’s disease, PSP and MSA-P.
Miller N1, Nath U2, Noble E1, Burn D3.
PMID: 28632098

3. Parkinsonism Relat Disord. 2017 Jun 12. pii: S1353-8020(17)30211-0. doi: 10.1016/j.parkreldis.2017.06.004. [Epub ahead of print]
DCTN1-related neurodegeneration: Perry syndrome and beyond.
Konno T1, Ross OA2, Teive HAG3, Sławek J4, Dickson DW2, Wszolek ZK5.
PMID: 28625595

4. Cortex. 2017 May 26. pii: S0010-9452(17)30166-1. doi: 10.1016/j.cortex.2017.05.011. [Epub ahead of print]
The role of the motor system in action naming in patients with neurodegenerative extrapyramidal syndromes.
Cotelli M1, Manenti R2, Brambilla M2, Borroni B 3.
PMID: 28625346

5. J Neural Transm (Vienna). 2017 Jun 15. doi: 10.1007/s00702-017-1743-6. [Epub ahead of print]
Assessment of serum uric acid as risk factor for tauopathies.
Schirinzi T1,2, Di Lazzaro G3, Colona VL3, Imbriani P3, Alwardat M4, Sancesario GM5, Martorana A3, Pisani A3.
PMID: 28620833